Tocqueville Asset Management L.P. Seagen Inc. Transaction History

Tocqueville Asset Management L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$191.51 - $216.16 $38,302 - $43,232	-200 Reduced 7.12%	2,608 $553,000
Q3 2022 Nov 10, 2022	SELL	$135.27 - $180.11 $405,810 - $540,330	-3,000 Reduced 51.65%	2,808 $384,000
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $86,894 - $103,590	-610 Reduced 9.5%	5,808 $986,000
Q2 2021 Aug 16, 2021	SELL	$135.08 - $161.1 $5,403 - $6,444	-40 Reduced 0.62%	6,418 $1.01 Million
Q1 2021 May 17, 2021	SELL	$137.51 - $190.8 $17,876 - $24,804	-130 Reduced 1.97%	6,458 $897,000

Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $1.08 Million - $1.4 Million	6,588 New	6,588 $1.15 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.